Ticker

Partnership to explore expanded cardiac screening, clinical research, and AI-assisted echocardiography in Costa Rica Toronto, Ontario – TheNewswire - April 1, 2026 – Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company ") ( TSXV: VPT; OTC: VPTDF ), a leader in AI-assisted cardiac imaging solutions, today announced a collaboration with the Health Division of the Montecristo Group to explore new clinical…

Partnership to explore expanded cardiac screening, clinical research, and AI-assisted echocardiography in Costa Rica Toronto, Ontario – TheNewswire - April 1, 2026 – Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company ") ( TSXV: VPT; OTC: VPTDF ), a leader in AI-assisted cardiac imaging solutions, today announced a collaboration with the Health Division of the Montecristo Group to explore new clinical…

/PRNewswire/ -- USANewsGroup.com News Commentary - Heart disease is a quiet crisis that is draining healthcare resources worldwide, currently costing the

Landmark partnership deploys hub-and-spoke model to close the cardiac care gap for Indigenous and underserved populations in British Columbia — with national and global expansion planned. Toronto, Ontario – TheNewswire - March 17, 2026 - Ventripoint Diagnostics Ltd. (" Ventripoint ", “ VPT ” or the " Company "), (TSXV:VPT; OTC:VPTDF) a leader in AI-assisted cardiac imaging, today announced a partnership with First…

Toronto, Ontario – TheNewswire - March 4, 2026 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “ Corporation ”, TSXV:VPT) announces it has received approval from the TSX Venture Exchange (“ TSXV ”) and issued of 291,344 common shares (“ Shares ”) for the payment of an aggregate of $36,989.01 of interest owing on certain outstanding Convertible Debentures issued by the Corporation on June 28, 2024, December 16,…